Power Reduction of an Embedded Pattern Recognition Myoelectric Control System
嵌入式模式识别肌电控制系统的功耗降低
基本信息
- 批准号:8520088
- 负责人:
- 金额:$ 15.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAgonistAlgorithmsAmputeesArtificial ArmBionicsBusinessesChicagoClinicalClinical DataConsumptionData SetDevelopmentDevicesDisabled PersonsDropsEnsureFosteringFreedomFutureGoalsGrantHealthHibernationHourIndividualInstitutesJointsKnowledgeLaboratoriesLimb ProsthesisLimb structureManufacturer NameMarketingMeasuresMedicineMilitary PersonnelMissionMonitorMuscleMyoelectric prosthesisOrthopedicsOutcomePatientsPatternPattern RecognitionPattern Recognition SystemsPersonal ComputersPersonsPhasePopulationProductivityProsthesisPublic HealthQuality of lifeRadioRehabilitation ResearchRehabilitation therapyResearchResearch Project GrantsResourcesSavingsSignal TransductionSimulateSleepSmall Business Innovation Research GrantStagingSystemTalentsTechniquesTechnologyTestingTimeTrainingUpper ExtremityWeightWireless TechnologyWorkarmbaseclinical applicationcommercial applicationdesigndisabilityimprovedimproved functioninglimb amputationoperationpreventprototypepublic health relevancereinnervationresearch clinical testingsuccesssystems researchtelemetering
项目摘要
DESCRIPTION (provided by applicant): Pattern recognition (PR) myoelectric control systems can dramatically improve an amputee patient's control over a powered prostheses, but they have not been made commercially available. Coapt, LLC, is a start-up stage company that is seeking to commercialize PR myoelectric control for the benefit of upper-limb amputees. The controller is based on research completed by the Rehabilitation Institute of Chicago's Center for Bionic Medicine. Numerous challenges, including clinically viable training and recalibration routines, have been overcame within the past decade, yet some still remain. One such challenge is to lower the power requirements of an embedded PR control system to an acceptable level such that the controller does not quickly drain the onboard prosthesis battery. The objective of this application is to lower the power requirements of the PR embedded control system such that it uses less than 10% of the battery's energy over a full day's use. Energy reduction is a critical item in the development of embedded control systems as it is directly related to the weight of the battery which must be attached to the prosthesis and carried by the patient whenever wearing the device. We will demonstrate the technical feasibility of the approach by the following two specific aims: (1) Develop power management algorithms to minimize power consumption of our pattern recognition controller in a manner that is transparent to the user, (2) Implement the power management techniques on the firmware of our pattern recognition controller. It is very important that our power management act in a manner that is transparent to the user. They must allow the overall control system to remain responsive to the user's command, even after long periods during which the system remains dormant. The proposed research is significant because it removes one of the few remaining clinical barriers preventing pattern recognition-based myoelectric control from being adopted. Ultimately, this research will help allow thousands of upper limb amputees to dramatically improve the control their prostheses, allowing for an improved quality of life.
描述(由申请人提供):模式识别(PR)肌电控制系统可以显着改善截肢患者对动力假肢的控制,但它们尚未商业化。 Coapt, LLC 是一家初创公司,致力于将 PR 肌电控制商业化,以造福上肢截肢者。该控制器基于芝加哥康复研究所仿生医学中心完成的研究。在过去的十年里,许多挑战,包括临床上可行的培训和重新校准程序,已经被克服,但仍然存在一些挑战。其中一个挑战是将嵌入式 PR 控制系统的功率要求降低到可接受的水平,以便控制器不会快速耗尽机载假肢电池。此应用的目标是降低 PR 嵌入式控制系统的功耗要求,使其在全天使用中使用的电池能量少于 10%。节能是嵌入式控制系统开发中的一个关键项目,因为它与电池的重量直接相关,电池必须连接到假肢上并由患者在佩戴设备时携带。我们将通过以下两个具体目标证明该方法的技术可行性:(1)开发电源管理算法,以对用户透明的方式最大限度地减少模式识别控制器的功耗,(2)实施电源管理技术在我们的模式识别控制器的固件上。我们的电源管理以对用户透明的方式进行,这一点非常重要。即使系统长时间处于休眠状态,它们也必须允许整个控制系统保持对用户命令的响应。这项研究意义重大,因为它消除了阻碍基于模式识别的肌电控制被采用的少数剩余临床障碍之一。最终,这项研究将帮助成千上万的上肢截肢者显着改善对假肢的控制,从而提高生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Blair Lock其他文献
Blair Lock的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Blair Lock', 18)}}的其他基金
Simultaneous Pattern Recognition Control of Powered Upper Limb Prostheses
动力上肢假肢的同步模式识别控制
- 批准号:
9345731 - 财政年份:2015
- 资助金额:
$ 15.05万 - 项目类别:
Development of a Clinically Viable Pattern Recognition Embedded System
临床上可行的模式识别嵌入式系统的开发
- 批准号:
8831819 - 财政年份:2013
- 资助金额:
$ 15.05万 - 项目类别:
Development of a Clinically Viable Pattern Recognition Embedded System
临床上可行的模式识别嵌入式系统的开发
- 批准号:
8935636 - 财政年份:2013
- 资助金额:
$ 15.05万 - 项目类别:
相似国自然基金
线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
- 批准号:82370171
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
多巴胺受体激动剂普拉克索通过Nrf2/GPX4/SLC7A11途径对全脑缺血再灌注损伤后铁死亡的脑保护机制研究
- 批准号:82271427
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
PPARα激动剂通过干扰EZH2稳定性发挥抗肿瘤效应的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究GLP-1受体激动剂通过调控小胶质细胞线粒体动力学改善视网膜缺血再灌注损伤的作用机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of PPARγ in astrocyte pathobiology after exposure to repetitive mild traumatic brain injury
PPARγ 在重复性轻度脑外伤后星形胶质细胞病理学中的作用
- 批准号:
10739968 - 财政年份:2023
- 资助金额:
$ 15.05万 - 项目类别:
Mentoring the next generation of researchers at the intersection of opioid use disorder and chronic pain
指导下一代研究人员研究阿片类药物使用障碍和慢性疼痛的交叉点
- 批准号:
10663642 - 财政年份:2023
- 资助金额:
$ 15.05万 - 项目类别:
Development of the OpiAID strength band platform
OpiAID 力量带平台的开发
- 批准号:
10684399 - 财政年份:2023
- 资助金额:
$ 15.05万 - 项目类别:
Developing, Implementing, and Pilot Testing an Informed Decision Aid for Opioid Agonist Therapies for Prisoners in Ukraine
为乌克兰囚犯开发、实施和试点测试阿片类药物激动剂疗法的知情决策辅助工具
- 批准号:
10531558 - 财政年份:2022
- 资助金额:
$ 15.05万 - 项目类别:
Generative neural networks for structure-based antibody design
用于基于结构的抗体设计的生成神经网络
- 批准号:
10705666 - 财政年份:2022
- 资助金额:
$ 15.05万 - 项目类别: